SHOX2 and laryngotracheoesophageal cleft: All of these results are similar to the results of this study, suggesting that clinical attention should be paid to the expression of SHOX2, RASSF1A and PTGER4 in patients with high risk of LC, and early diagnosis and treatment should be carried out in order to improve the long-term survival rate of patients.